# Symmune Therapeutics, LLC — Form D

Symmune Therapeutics, LLC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-09. The offering totals $300K, of which $125K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-08-09
- Form: D
- Accession: 0001749423-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $125K
- Remaining: $175K
- Investors: 5
- Date of first sale: 2018-07-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-318830

## Issuer

- Name: Symmune Therapeutics, LLC
- CIK: 0001749423
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 201 West Main Street, DURHAM, NC, 27701
- Phone: 650-823-1706

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Jesse Keicher | Director | Durham, NC |
| Jesse Keicher | Executive Officer | Durham, NC |
| Jesse Keicher | Promoter | Durham, NC |

## More

- [CIK 1749423 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1749423&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001749423-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.